Acute rhinitis
Conditions
Interventions
Experimental group:Sanfeng Tongqiao dropping pills
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of Western medicine for acute rhinitis; 2. In line with the syndrome differentiation standard of TCM external wind and cold syndrome and heat syndrome of lung depression; 3. Aged >18 years, regardless of gender; 4. Acute onset, duration within 48 hours; 5. Participate voluntarily and sign informed consent in person.
Exclusion criteria
Exclusion criteria: 1. Patients who have taken Chinese and Western medicines to treat acute rhinitis after the onset of the disease; 2. Patients suffering from infectious diseases such as influenza, measles, scarlet fever, whooping cough, chickenpox and diphtheria; 3. Patients with allergic rhinitis, vascular active rhinitis, atrophic rhinitis, sinusitis, nasal tumor, and severe deviation of nasal septum; 4. Patients with nasal mucosa dysfunction due to previous nasal surgery, radiotherapy and other reasons; 5. Patients with infectious diseases of the throat or lower respiratory tract requiring the combined use of antibiotics or other drugs with similar effects to the test drugs; 6. Have serious diseases of the heart, lung, liver, kidney or blood system, or serious diseases affecting their survival, such as malignant tumors; 7. Body temperature (axillary temperature) >=37.3?; 8. Abnormal liver and kidney function examination (ALT and AST>= 1.5 times the upper limit of normal value, Cr > the upper limit of normal value); 9. Leukocyte count > 1.2 times the upper limit of normal, neutrophil count > the upper limit of normal, and the investigators judged that bacterial infection of acute rhinitis; 10. Unable to cooperate or unwilling to cooperate because of neurological or mental illness; 11. Suspected or confirmed history of alcohol or drug abuse; 12. Pregnant or lactating patients or those who have recently planned to give birth; 13. Known or suspected allergy to the test drug or its components, or allergic disposition; 14. Participated in or is participating in other clinical trials within the last 3 months; 15. Patients considered unsuitable for this clinical trial by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease response rate after 4 days of administration; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical recovery time of disease;Clinical cure rate, significant efficiency and effective rate of TCM syndrome after 4 days of medication;The disappearance time and rate of nasal obstruction, runny nose, sneezing and hypoolfactory after 4 days of medication;Changes of TCM syndrome total score and single symptom score after 4 days of medication;Quantitative changes in anterior nasal examination after 4 days of administration; | — |
Countries
China
Contacts
Public ContactRuan Yan
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed